<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Factors associated with an increased risk of congenital heart disease</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Factors associated with an increased risk of congenital heart disease</h1>
<div class="graphic"><div class="figure"><div class="ttl">Factors associated with an increased risk of congenital heart disease</div><div class="cntnt"><table cellspacing="0"><colgroup span="3" width="33%"></colgroup> <tbody> <tr class="divider_bottom"> <td class="subtitle1"> </td> <td class="subtitle1">Estimated risk*</td> <td class="subtitle1">Associated CHD lesions</td> </tr> <tr class="divider_bottom"> <td><strong>Prematurity (gestational age &lt;37 weeks)</strong><sup>[1]</sup></td> <td>OR 2.4 (95% CI 2.2-2.7)</td> <td>Various</td> </tr> <tr class="divider_bottom"> <td><strong>Multifetal pregnancy</strong><sup>[2]</sup></td> <td>OR 4.53 (95% CI 4.28-4.8)</td> <td>RVOTO lesions, VSD, ASD</td> </tr> <tr> <td colspan="3"><strong>In utero infection</strong></td> </tr> <tr> <td class="indent1">Rubella<sup>[3]</sup></td> <td>Cardiac defects occur in 10 to 20% of infants with congenital rubella</td> <td>PDA and peripheral pulmonary artery stenosis</td> </tr> <tr class="divider_bottom"> <td class="indent1">Maternal influenza or flu-like illness<sup>[4]</sup></td> <td>OR 2.04 (95% CI 1.27-3.27)</td> <td>RVOTO lesions</td> </tr> <tr> <td colspan="3"><strong>Maternal factors</strong><sup>[2]</sup></td> </tr> <tr> <td class="indent1">Preeclampsia<sup>[5]</sup></td> <td>RR 1.57 (95% CI 1.48-1.67)</td> <td>Septal defects</td> </tr> <tr> <td class="indent1">PKU<sup>[6]</sup></td> <td>Cardiac defects occur in 15% of infants with poorly controlled maternal PKU</td> <td>CoA and HLHS</td> </tr> <tr> <td class="indent1">Diabetes mellitus</td> <td>OR 4.65 (95% CI 4.13-5.24)</td> <td>Heterotaxy syndrome, conotruncal defects, AVSD, LVOTO and RVOTO lesions</td> </tr> <tr> <td class="indent1">Hypertension</td> <td>OR 1.81 (95% CI 1.61-2.03)</td> <td>RVOTO, VSD, ASD</td> </tr> <tr> <td class="indent1">Obesity</td> <td>OR 1.48 (95% CI 1.32-1.65)</td> <td>Various</td> </tr> <tr> <td class="indent1">Thyroid disorders</td> <td>OR 1.45 (95% CI 1.26-1.67)</td> <td>Various</td> </tr> <tr> <td class="indent1">Systemic connective tissue disorders</td> <td>OR 3.01 (95% CI 2.23-4.06)</td> <td>Heterotaxy syndrome</td> </tr> <tr> <td class="indent1">Epilepsy and mood disorders<sup>¶</sup></td> <td>OR 1.41 (95% CI 1.16-1.72)</td> <td>Various</td> </tr> <tr> <td class="indent1">Age ≥40 years</td> <td>OR 1.48 (95% CI 1.39-1.58)</td> <td>AVSD</td> </tr> <tr> <td class="indent1">Alcohol or substance use</td> <td>OR 1.88 (95% CI 1.74-2.04)</td> <td>RVOTO, VSD, ASD</td> </tr> <tr> <td class="indent1">First-trimester cigarette smoking<sup>[7]</sup></td> <td> <p>OR 1.9 (95% CI 1.04-3.45)</p> <p>OR 1.32 (95% CI 1.06-1.65)</p> OR 1.36 (95% CI 1.04-1.78)</td> <td> <p>Truncus arteriosus</p> <p>RVOTO</p> Secundum ASD</td> </tr> <tr class="divider_bottom"> <td class="indent1"> <p>Maternal medications during pregnancy<sup>[6,8]</sup>:</p> <p class="extra_spacing_top indent1">Increased risk of CHD has been reported with thalidomide, ACE inhibitor, retinoic acid, NSAIDs, phenytoin, and lithium</p> </td> <td>Estimates vary</td> <td> <p>Various</p> <p>NSAIDs are associated with D-TGA, AVSD, VSD, bicuspid aortic valve</p> Lithium has been reported to be associated with Ebstein anomaly<sup>Δ</sup></td> </tr> <tr class="divider_bottom"> <td><strong>Assisted reproductive technology</strong><sup>[9]</sup></td> <td>RR 1.64 (95% CI 1.30-2.07)</td> <td>Various</td> </tr> <tr> <td colspan="3"><strong>Family history of CHD</strong><sup>[10]</sup></td> </tr> <tr> <td class="indent1">First-degree relative with any CHD</td> <td>RR 3.21 (95% CI 2.96-3.49)</td> <td>Various</td> </tr> <tr> <td class="indent1">Second-degree relative with any CHD</td> <td>RR 1.78 (95% CI 1.09-2.91)</td> <td>Various</td> </tr> <tr> <td class="indent1">First-degree relative with heterotaxy</td> <td>RR 79.1 (95% CI 32.9-190.0)</td> <td>Heterotaxy</td> </tr> <tr> <td class="indent1">First-degree relative with RVOTO</td> <td>RR 48.6 (95% CI 27.5-85.6)</td> <td>RVOTO</td> </tr> <tr> <td class="indent1">First-degree relative with AVSD</td> <td>RR 24.3 (95% CI 12.2-48.7)</td> <td>AVSD</td> </tr> <tr> <td class="indent1">First-degree relative with LVOTO</td> <td>RR 12.9 (95% CI 7.48-22.20)</td> <td>LVOTO</td> </tr> <tr> <td class="indent1">First-degree relative with conotruncal defect</td> <td>RR 11.7 (95% CI 8.01-17.00)</td> <td>Conotruncal defect</td> </tr> <tr> <td class="indent1">First-degree relative with isolated ASD</td> <td>RR 7.07 (95% CI 4.51-11.10)</td> <td>ASD</td> </tr> <tr> <td class="indent1">First-degree relative with isolated VSD</td> <td>RR 3.41 (95% CI 2.20-5.29)</td> <td>VSD</td> </tr> </tbody></table></div><div class="graphic_footnotes"><p>CHD: congenital heart disease; OR: odds ratio; RVOTO: right ventricular outflow tract obstruction; VSD: ventricular septal defect; ASD: atrial septal defect; PDA: patent ductus arteriosus; RR: relative risk; PKU: phenylketonuria; CoA: coarctation of the aorta; HLHS: hypoplastic left heart syndrome; AVSD: atrioventricular septal defect; LVOTO: left ventricular outflow tract obstruction; ACE: angiotensin-converting enzyme; NSAID: nonsteroidal antiinflammatory drug; D-TGA: D-transposition of the great arteries.</p>
<p>* These estimates are for relative risk. The absolute risk depends on the baseline prevalence of the CHD defect. The overall prevalence of CHD in the general population is approximately 1%.</p>
<p>¶ The association of CHD with mood disorders is most likely reflective of the medications used in the treatment of these disorders.</p>
Δ The association of lithium with Ebstein anomaly is controversial; however, screening for CHD is generally recommended for infants exposed to lithium during the first or second trimester of pregnancy. Refer to the UpToDate topics on teratogenic and postnatal risks of lithium and prenatal screening for fetal cardiac abnormalities for more details.</div><div class="graphic_reference">References:
<ol>
<li>Tanner K, Sabrine N, Wren C. Cardiovascular malformations among preterm infants. Pediatrics 2005; 116:e833.</li>
<li>Liu S, Joseph KS, Lisonkova S, et al. Association between maternal chronic conditions and congenital heart defects: A population-based cohort study. Circulation 2013; 128:583.</li>
<li>Reef SE, Plotkin S, Cordero JF, et al. Preparing for elimination of congenital Rubella syndrome (CRS): Summary of a workshop on CRS elimination in the United States. Clin Infect Dis 2000; 31:85.</li>
<li>Oster ME, Riehle-Colarusso T, Alverson CJ, Correa A. Associations between maternal fever and influenza and congenital heart defects. J Pediatr 2011; 158:990.</li>
<li>Auger N, Fraset WD, Healy-Profitos J, Abour L. Association between preeclampsia and congenital heart defects. JAMA 2015; 314:1588.</li>
<li>Jenkins KJ, Correa A, Feinstein JA, et al. Noninherited risk factors and congenital cardiovascular defects: Current knowledge: A scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: Endorsed by the American Academy of Pediatrics. Circulation 2007; 115:2995.</li>
<li>Alverson CJ, Strickland MJ, Gilboa SM, Correa A. Maternal smoking and congenital heart defects in the Baltimore-Washington Infant Study. Pediatrics 2011; 127:e647.</li>
<li>Diav-Citrin O, Shechtman S, Tahover E, et al. Pregnancy outcome following in utero exposure to lithium: A prospective, comparative, observational study. Am J Psychiatry 2014; 171:785.</li>
<li>Wen J, Jiang J, Ding C, et al. Birth defects in children conceived by in vitro fertilization and intracytoplasmic sperm injection: A meta-analysis. Fertil Steril 2012; 97:1331.</li>
<li>Øyen N, Poulsen G, Boyd HA, et al. Recurrence of congenital heart defects in families. Circulation 2009; 120:295.</li>
</ol></div><div id="graphicVersion">Graphic 103088 Version 6.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
